Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
EJNMMI Radiopharmacy and Chemistry is Scopus-indexed (Q2, CiteScore 4.3), WoS ESCI, DOAJ. Published by Springer Science and Business Media Deutschland GmbH.
Checked against the index lists dated .
ISSN 2365-421XVerify ISSN ↗
Publisher: Springer Science and Business Media Deutschland GmbH
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Radiology, Nuclear Medicine and Imaging | 115 / 361 | 68th | Q2 |
| Pharmacology (medical) | 120 / 278 | 57th | Q2 |
| Analytical Chemistry | 82 / 160 | 49th | Q3 |
| Pharmacology | 171 / 328 | 48th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2016–present, best quartile Q2, CiteScore 4.3.
EJNMMI Radiopharmacy and Chemistry is Q2 in Radiology, Nuclear Medicine and Imaging (rank 115 of 361), Q2 in Pharmacology (medical) (rank 120 of 278) and Q3 in Analytical Chemistry (rank 82 of 160), by CiteScore 2025. It is ranked in 4 subject areas in all.
EJNMMI Radiopharmacy and Chemistry is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.3, which places it in quartile Q2 at the 68th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.752, quartile Q1, with an H-index of 36.
The publisher lists an article processing charge of about US$2,290 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
EJNMMI Radiopharmacy and Chemistry is published by Springer Science and Business Media Deutschland GmbH. Its ISSN is 2365-421X.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
EJNMMI Radiopharmacy and Chemistry has an h-index of 41 and a 2-year mean of 3.88 citations per paper (OpenAlex). Its Scopus CiteScore is 4.3, quartile Q2. On 2-year citations it ranks #43 of 346 Scopus journals in Radiology, Nuclear Medicine and Imaging.
EJNMMI Radiopharmacy and Chemistry published 91 papers in 2025; its busiest recent year was 2024 with 94. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from United States (17.5%), France (11%) and China (9.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.